ABUS Arbutus Biopharma Corporation
$4.35
▼ 1.58%
38
Value
13
P/E-24.88
8
P/B10.88
41
P/S60.83
0
EV/EBITDA-22.81
5
Growth
67
Revenue Growth128.2%
100
EPS Growth55.3%
47
FCF Growth39.1%
49
Momentum
68
12-Month Return31.0%
70
3-Month Return18.5%
89
1-Month Return-0.7%
52
RSI (14)33.33
50
50/200 MABullish
75
Profitability
15
ROE-42.4%
43
ROA-35.4%
0
Gross Margin36.2%
37
Operating Margin-348.7%
0
Net Margin-237.9%
0
FCF Yield-4.6%
0
Risk
25
Beta0.62
55
60-Day Volatility43.4%
0
QScore Analysis